Jordan drugmaker expects resurgence in the second half despite 41% fall in pre-tax profit as governments increase spending on welfare Source: FT.com - Pharmaceuticals
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,